Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants
Clinical trial NCT01204658 · COMPLETED
Trial details
- NCT number
- NCT01204658
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-27
- Primary completion
- 2011-11-03
- Enrollment
- 576
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.